Leveraging RWE and disparate data sets needed for therapeutics regarding diverse patients

Looking forward to this session? Share it!

• Understanding the importance of patient diversity in clinical trials for RWE
• Leveraging target profiles to expand the demographic mapping
• The key factors required in the future for regulatory submissions leveraging experiential and RWE data sources and testing